Leucine

Leucine, abbreviated Leu or L, is one of the amino acids that humans must obtain from food because the body cannot synthesize it. It has the molecular formula C6H13NO2 and a nonpolar, branched isobutyl side chain, which places it among the branched-chain amino acids together with isoleucine and valine. The biologically active form is L-leucine, and the name traces back to the Greek word for white, a nod to the white crystalline powder first isolated in the nineteenth century. In food manufacturing it also serves as a flavoring agent under the E number E641.

Of all the amino acids, leucine has the strongest reputation as an anabolic trigger. It acts as a signal that initiates the building of new muscle protein, and much of that effect is channeled through the mechanistic target of rapamycin (mTOR) pathway ^[1]. Some of its activity is attributed to a downstream metabolite, beta-hydroxy-beta-methylbutyrate (HMB), which has been shown to raise muscle protein synthesis and to blunt muscle breakdown ^[1]. In animal work, a leucine-enriched diet restored the normal, meal-driven suppression of protein breakdown in the muscle of aged rats, hinting at a role in countering age-related muscle loss ^[2].

Leucine is one of only two purely ketogenic amino acids, meaning its carbon skeleton is broken down into acetyl-CoA and related molecules rather than into glucose. Its metabolism begins when a branched-chain aminotransferase converts it into alpha-ketoisocaproate, after which the pathway branches toward energy production or the synthesis of other compounds. Because it competes with other amino acids for transport and can influence how the body handles niacin, very high intakes have historically been linked to metabolic disturbances.

Interest in leucine extends well beyond muscle. Researchers have examined its influence on insulin signaling, where elevated blood leucine has been associated with insulin resistance, along with more surprising effects in the brain; both L-leucine and its mirror-image form D-leucine were found to protect mice against chemically and electrically induced seizures, with D-leucine halting ongoing seizures about as effectively as a standard anticonvulsant but without sedation ^[3]. As a supplement it is sold on its own and as part of branched-chain amino acid blends, although studies that mapped a tolerable upper intake level found that amounts well above dietary needs can raise blood ammonia ^[4].

In the diet, leucine is abundant in animal and plant proteins, with especially high levels in whey and soy protein, meat, fish, eggs, nuts, and legumes. It is not a controlled substance and is generally regarded as safe as a food component, appearing throughout the food supply both naturally and as an added ingredient.

Very safe at normal intakes. Very high isolated doses can throw off the balance of the other branched-chain amino acids and may transiently affect blood sugar signaling. People with rare amino acid metabolism disorders should avoid supplementing.

Leucine is an essential branched-chain amino acid, and its one well documented drug interaction comes from transport rather than metabolism. Leucine is a large neutral amino acid, and it competes with levodopa for the same carrier at the intestinal wall and again at the blood brain barrier. A leucine-rich protein load taken near a levodopa dose can delay that dose's onset, shorten its benefit or cause an outright dose failure; about 6% of people with Parkinson's disease taking levodopa link their motor fluctuations to protein timing, and concentrated branched-chain supplements are a more predictable competitor than a mixed meal.

Leucine also stimulates insulin release directly from pancreatic beta cells, so in principle it adds to the effect of insulin or a sulfonylurea, though the shift is small at supplement intakes and has not been shown to cause hypoglycemia.

Otherwise leucine is unremarkable. It has no cytochrome P450 activity of its own and no documented interaction with anticoagulants, antibiotics or psychiatric medication. In maple syrup urine disease the constraint is a metabolic block rather than a drug interaction, since leucine cannot be cleared normally at all.

Checking a whole stack? Run it through interactions + stacks.